K

Synvect logo

Synvect

Healthcare & Life Sciences

Recent Finacing

Seed

Recent Raise

$3M


Synvect is a biotechnology company that develops CRISPR-based technology to control mosquito populations by producing sterile male mosquitoes to suppress disease transmission.

Total Funding

$23M

Headquarters

San Diego, USA

Founded

N/A

Focus Areas

Biotechnology
CRISPR
Mosquito Control
Eco-friendly
Sterile Insect Technique
Disease Prevention

Investors

Antler logo
Bill & Melinda Gates Foundation logo
Redbud logo
NuFund logo